The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer
Clinical trial NCT04326296 · UNKNOWN
Trial details
- NCT number
- NCT04326296
- Sponsor
- LiNing
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-30
- Primary completion
- 2022-09-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.